This elevated TfR1 expression enables targeted therapeutic strategies, such as TransTACs, which exploit TfR1-mediated endocytosis to selectively degrade membrane proteins crucial for tumor survival and drug resistance, offering a novel approach for precise cancer treatment (18). Here, TFRC is linked to neoplasm.